A comprehensive proteomic study has revealed that lethal melanomas overexpress mitochondrial protein synthesis and metabolic pathways that sustain tumor growth. Targeting these pathways with select antibiotics that inhibit mitochondrial ribosomes showed potent anti-melanoma effects in vitro. These findings indicate new therapeutic angles exploiting mitochondrial vulnerabilities in melanoma, potentially transforming treatment of this rapidly progressive skin cancer.